EXICURE, INC. business relationships

Companies named in EXICURE, INC.’s 10-K filed 2026-03-25, and public companies whose annual reports name EXICURE, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 3.5 / 10
AI naming: <1 / 100
Agent readiness: 0 / 100
AI adoption: 0 / 100

Named in EXICURE, INC.’s annual report 1

Bluejay Therapeutics, Inc.Licensor4.2
“In January 2024, we entered into a patent license agreement (the "Patent License Agreement") to develop cavrotolimod for potential treatment for hepatitis with Bluejay Therapeutics, Inc. ("Bluejay"), a private clinical stage biopharmaceutical company.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.